Seattle Genetics (SGEN)
Add to Watchlists Create an Alert
34.95
-0.40 -1.13%
NASDAQ
May 24, 4:30PM
BATS Real time
Currency in USD
Seattle Genetics Revenue Quarterly:
63.91M for Dec. 31, 2012Seattle Genetics Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 63.91M |
| Sept. 30, 2012 | 49.83M |
| June 30, 2012 | 48.82M |
| March 31, 2012 | 48.24M |
| Dec. 31, 2011 | 48.89M |
| Sept. 30, 2011 | 20.67M |
| June 30, 2011 | 13.05M |
| March 31, 2011 | 12.17M |
| Dec. 31, 2010 | 8.146M |
| Sept. 30, 2010 | 15.99M |
| June 30, 2010 | 36.88M |
| March 31, 2010 | 46.46M |
| Dec. 31, 2009 | 21.77M |
| Sept. 30, 2009 | 11.65M |
| June 30, 2009 | 9.408M |
| March 31, 2009 | 9.142M |
| Dec. 31, 2008 | 10.07M |
| Sept. 30, 2008 | 8.079M |
| June 30, 2008 | 10.00M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
SGEN Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Cytokinetics | 0.821M |
| Targacept | 3.536M |
| Onyx Pharmaceuticals | 145.49M |
SGEN Revenue Quarterly Rankings
| Overall |
65th percentile 2793 of 8009 |
| Sector |
72nd percentile 188 of 687 in Healthcare |
| Industry |
89th percentile 26 of 248 in Biotechnology |
SGEN Revenue Quarterly Range, Past 5 Years
| Minimum | 8.079M | Sep 2008 |
| Maximum | 63.91M | Dec 2012 |
| Average | 25.96M |